{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:12:31Z","timestamp":1790010751869,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijregi.2026.100933","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:50:48Z","timestamp":1781801448000},"page":"100933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SARS-CoV-2 IgG seropositivity among people living with and without HIV in the first year of the COVID-19 pandemic in Haiti and Tanzania"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-8911","authenticated-orcid":false,"given":"Alexandra A.","family":"Cordeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Willkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Issarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Dorvil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen F.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stalz Charles","family":"Vilbrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Severe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean William","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Appolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100933_bib0001","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/infdis\/jiab616","article-title":"Similar risk of severe acute respiratory syndrome coronavirus 2 infection and similar nucleocapsid antibody levels in people with well-controlled human immunodeficiency virus (HIV) and a comparable cohort of people without HIV","volume":"225","author":"Verburgh","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0002","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jmii.2020.09.005","article-title":"Antibody response to SARS-CoV-2 in people living with HIV","volume":"54","author":"Yamamoto","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijregi.2026.100933_bib0003","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/09564624221076629","article-title":"The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit","volume":"33","author":"Gudipati","year":"2022","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijregi.2026.100933_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2026.100933_bib0005","unstructured":"World Health Organization. Coronavirus disease (COVID-19) dashboard with vaccination data. 2019. [Accessed Dec 15 2025]. https:\/\/covid19.who.int\/region\/amro\/country\/ht."},{"key":"10.1016\/j.ijregi.2026.100933_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004107","article-title":"Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies","volume":"19","author":"Bergeri","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijregi.2026.100933_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286665","article-title":"Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country","volume":"18","author":"Kabor\u00e9","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100933_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/23259582221077943","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies among HIV infected individuals attending Art Centre at Pune: a cross-sectional study","volume":"21","author":"Ghate","year":"2022","journal-title":"J Int Assoc Provid Aids Care"},{"key":"10.1016\/j.ijregi.2026.100933_bib0009","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/cid\/ciac198","article-title":"Seroprevalence of severe acute respiratory syndrome coronavirus 2 after the second wave in South Africa in human immunodeficiency virus\u2013infected and uninfected persons: a cross-sectional household survey","volume":"75","author":"Wolter","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0010","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3018(21)00072-2","article-title":"SARS-CoV-2 seroprevalence, and IgG concentration and Pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","volume":"8","author":"Spinelli","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijregi.2026.100933_bib0011","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1038\/s41467-021-26137-7","article-title":"Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV","volume":"12","author":"Alrubayyi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijregi.2026.100933_bib0012","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis","volume":"11","author":"Ssentongo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijregi.2026.100933_bib0013","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0000000000002836","article-title":"Risk of adverse coronavirus disease 2019 outcomes for people living with HIV","volume":"35","author":"Mellor","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ijregi.2026.100933_bib0014","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/cid\/ciab736","article-title":"Rapid emergence and spread of severe acute respiratory syndrome coronavirus 2 gamma (P.1) Variant in Haiti","volume":"74","author":"Tagliamonte","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000781","article-title":"The burden of respiratory conditions in the emergency department of Muhimbili National Hospital in Tanzania in the first two years of the COVID-19 pandemic: a cross sectional descriptive study","volume":"2","author":"Ndumwa","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.ijregi.2026.100933_bib0016","unstructured":"Pan American Health Organization\/World Health Organization. Start of the COVID-19 vaccination campaign in Haiti: first persons vaccinated less than 48 hours after the arrival of the first vaccines. [accessed May 12 2026]. https:\/\/www.paho.org\/en\/news\/17-7-2021-start-covid-19-vaccination-campaign-haiti-first-persons-vaccinated-less-48-hours. 2021."},{"key":"10.1016\/j.ijregi.2026.100933_tboref0003","unstructured":"United Nations, Africa Renewal. Tanzania receives first COVID-19 vaccine batch. 2021. [Accessed May 12 2026]."},{"key":"10.1016\/j.ijregi.2026.100933_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002864","article-title":"Factors associated with COVID-19 vaccine hesitancy and uptake among populations in the West Department of Haiti","volume":"4","author":"Etienne-Mesubi","year":"2024","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.ijregi.2026.100933_tboref0004","unstructured":"World Health Organization. From below 10 to 51 percent - Tanzania increases COVID-19 vaccination coverage. 2023. [Accessed May 12 2026]."},{"key":"10.1016\/j.ijregi.2026.100933_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002357","article-title":"Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial","volume":"14","author":"Koenig","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijregi.2026.100933_bib0022","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1186\/s12889-020-09734-x","article-title":"The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort","volume":"20","author":"Lookens","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijregi.2026.100933_bib0023","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1093\/infdis\/jiad564","article-title":"A bedaquiline, pyrazinamide, levofloxacin, linezolid, and clofazimine second-line regimen for tuberculosis displays similar early bactericidal activity as the standard rifampin-based first-line regimen","volume":"230","author":"Zainabadi","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0024","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/jch.13975","article-title":"Blood pressure, T cells, and mortality in people with HIV in Tanzania during the first 2 years of antiretroviral therapy","volume":"22","author":"Reis","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ijregi.2026.100933_bib0025","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1093\/cid\/ciab758","article-title":"Similar antibody responses against severe acute respiratory syndrome coronavirus 2 in individuals living without and with human immunodeficiency virus on antiretroviral therapy during the first South African infection wave","volume":"75","author":"Snyman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0026","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.026","article-title":"SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV","volume":"85","author":"Giannone","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijregi.2026.100933_bib0027","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijid.2022.03.021","article-title":"SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study","volume":"118","author":"Shanaube","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0028","article-title":"A longitudinal analysis of SARS-CoV-2 antibody responses among people with HIV","volume":"9","author":"Alcaide","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijregi.2026.100933_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231276","article-title":"Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination","volume":"14","author":"Motsoeneng","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijregi.2026.100933_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/jiac343","article-title":"Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant","volume":"227","author":"Hwa","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158402","article-title":"Lower SARS-CoV-2\u2013specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19","volume":"7","author":"Schuster","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijregi.2026.100933_bib0032","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1186\/s12879-021-06723-2","article-title":"People living with HIV easily lose their immune response to SARS-CoV-2: result from a cohort of COVID-19 cases in Wuhan, China","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100933_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/QAI.0000000000003120","article-title":"SARS-CoV-2 seropositivity and HIV viral load among Mozambican pregnant women","volume":"92","author":"Gonz\u00e1lez","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijregi.2026.100933_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2023.1212220","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in HIV-positive and HIV-negative patients in clinical settings in Douala, Cameroon","volume":"3","author":"Kwedi Nolna","year":"2023","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.ijregi.2026.100933_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004246","article-title":"Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: a randomized open-label trial from Haiti","volume":"20","author":"Dorvil","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijregi.2026.100933_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307003","article-title":"HIV viral suppression in the era of dolutegravir use: findings from a national survey in Tanzania","volume":"19","author":"Kamori","year":"2024","journal-title":"PLoS One"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:44:31Z","timestamp":1790009071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S2772707626000962"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100933","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 IgG seropositivity among people living with and without HIV in the first year of the COVID-19 pandemic in Haiti and Tanzania","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100933"}}